Efficacy of photodynamic therapy in vulvar lichen sclerosus treatment based on immunohistochemical analysis of CD34, CD44, myelin basic protein, and Ki67 antibodies

International Journal of Gynecological Cancer

Volumn 20, Issue 5, 2010, Pages 879-887

  Olejek, Anita ^a   Steplewska, Katarzyna ^a   Gabriel, Andrzej ^a   Kozak Darmas, Iwona ^a   Jarek, Anna ^a   Kellas Śleczka, Sylwia ^b   Bydliński, Filip ^a   Sieroń Stoltny, Karolina ^a   Horak, Stanislaw ^a   Cheamicki, Artur ^a,c   Sieroń, Aleksander ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c Women's Health ^*  (Poland)

Author keywords

Immunohistochemistry; Lichen sclerosus; Photodynamic therapy; Vulva

Indexed keywords

CD34 ANTIGEN; EMOLLIENT AGENT; HERMES ANTIGEN; KI 67 ANTIGEN; MYELIN BASIC PROTEIN; STEROID;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER REGRESSION; CELL PROLIFERATION; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; OLIGODENDROGLIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SCHWANN CELL; TREATMENT OUTCOME; VASCULARIZATION;

ANTIGENS, CD34; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; MYELIN BASIC PROTEINS; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS;

EID: 77956868665     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d94f05     Document Type: Article

References (24)

1. Pugliese JM, Morey AF, Petersom AC. Lichen sclerosus: Review of the literature and current recommendations for management. J Urol. 2007;178:2268Y2276.
2. Rossi E, Pavanello, Franchella A. Lichen sclerosus in children with phimosis. Minerva Pediatr. 2007;59:761Y765.
3. Poindexter G, Morrel DS. Anogenital pruritus: Lichen sclerosus in children. Pediatr Ann. 2007;36:785Y791.
4. Regauer S, Liegl B, Reich O, et al. Vulvar lichen sclerosus. The importance of early clinical and histological diagnosis. Hautarzt. 2004;55:158Y164.
5. Hall D. Lichen sclerosus: Early diagnosis is the key to treatment. Nurse Pract. 1996;21:57Y58, 61Y62.
6. Loening-Baucke V. Lichen sclerosus et atrophicus in children. Am J Dis Child. 1991;145:1058Y1061.
7. Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol. 2005;84:273.
8. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777Y1783.
9. Smith YR, Haefner HK. Vulvar lichen sclerosus: Pathophysiology and treatment. Am J Clin Dermatol. 2004;5:105Y125.
10. Von Tappeiner H, Jodlbauer A. Die sensibilisierende Wirkung fluorescierender Substanzen. Gesammelte Untersuchungen über die photodynamische Erscheinung, FCW Vogel, Leipzig 1907.
11. von Tappeiner H, Jesionek A. Therapeutische Versuche mit fluorescierenden Stoffen. Münch Med Wochenschr. 1903;47:2042Y2044.
12. Meyer-Betz. Untersuchungen über die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivative des Blut- und Gallenfarbstoffs. Dtsch Arch Klin Med. 1913;112:476Y503.
13. Szeimies R, Calzavara-Pinton P, Karrer S, et al. Topical photodynamic therapy in dermatology. J of Photochemistry and Photobiology. 1996;36:213Y219.
14. Ascencio M, Collinet P, Cosson M, et al. The place of photodynamic therapy in gynecology. Gynecol Obstet Fertil. 2007;35:1155Y1165.
15. Olejek A, Rembielak-Stawecka B, Kozak-Darmas I, et al. Photodynamic diagnosis and therapy in gynecologyVcurrent knowledge. Ginekol Pol. 2004;75:228Y234.
16. Kaya G, Augsburger E, Stamenkovic I, et al. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus and atrophicus. J Invest Dermatol. 2000;115:1054Y1058.
17. Calicoglu E, Sorg O, Tran C, et al. UVA and UVB decrease the expression of CD44 and hyaluronate in mouse epidermis, which is counteracted by topical retinoids. Photochem Photobiol. 2006;82:1342Y1347.
18. Kaya G, Saurat JH. Restored CD44 expression In lichen sclerosus et atrophicus and clinical improvement with topical application of retinaldehyde. Br J Dermatol. 2005;152:570Y572.
19. Saravanamuthu J, Reid WM, George DS, et al. The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis. Gynecol Oncol. 2003;89:251Y258.
20. Li C, Bian D, Chen W, et al. Focused ultrasound therapy of vulvar dystrophies: A feasibility study. Obstet Gynecol. 2004;104:915Y921.
21. Cattaneo A, Bracco GL, Maestrini G. Lichen sclerosus and squamosus hyperplasia of the vulva. A clinical study of medical treatment. J Reprod Med. 1991;36:301Y305.
22. Rolfe KJ, Crow JC, Reid WM, et al. The effect of topical corticosteroids on Ki 67 and p53 expression in vulvar lichen sclerosus. Br J Dermatol. 2002;147:503Y508.
23. Rolfe KJ, Eva LJ, MacLean AB, et al. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer. 2001;11:113Y118.
24. Zwislak AA, McCluggage WG, Donnelly RF, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed. 2009;25:111Y113.